奥精医疗股价涨5.15%，融通基金旗下1只基金位居十大流通股东，持有240万股浮盈赚取288万元

Group 1 - The core viewpoint of the news is that Aojing Medical has seen a stock price increase of 5.15%, reaching 24.50 yuan per share, with a trading volume of 1.11 billion yuan and a turnover rate of 3.44%, resulting in a total market capitalization of 33.57 billion yuan [1] - Aojing Medical, established on December 22, 2004, and listed on May 21, 2021, focuses on the research, production, and sales of high-end biomedical materials and related medical devices [1] - The main revenue composition of Aojing Medical includes: 骼金 74.91%, 颅瑞 16.35%, 齿贝 4.15%, 口腔种植体 2.70%, and other products 1.87% [1] Group 2 - From the perspective of Aojing Medical's top ten circulating shareholders, a fund under Rongtong Fund has entered the top ten shareholders, holding 2.4 million shares, which accounts for 1.75% of the circulating shares [2] - The Rongtong Health Industry Flexible Allocation Mixed A/B fund (000727) has achieved a year-to-date return of 11.06%, ranking 1397 out of 8861 in its category, and a one-year return of 29.24%, ranking 4302 out of 8126 [2] - The fund manager of Rongtong Health Industry Flexible Allocation Mixed A/B is Wan Minyuan, who has a total fund asset scale of 4.763 billion yuan and has achieved a best fund return of 151.58% during his tenure [3]